CHRDL1 and pancreatic adenocarcinoma: According to Figure 2A, the expression of CHRDL1 was markedly downregulated in most cancers but upregulated in glioma, brain lower grade glioma, pancreatic adenocarcinoma, acute myeloid leukemia and thymoma.